nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—ALB—atherosclerosis	0.302	1	CbGaD
Pipotiazine—ALB—Rosuvastatin—atherosclerosis	0.0885	0.16	CbGbCtD
Pipotiazine—CYP2C19—Rosuvastatin—atherosclerosis	0.0574	0.103	CbGbCtD
Pipotiazine—CYP2C19—Simvastatin—atherosclerosis	0.0534	0.0962	CbGbCtD
Pipotiazine—CYP2C19—Lovastatin—atherosclerosis	0.0522	0.0942	CbGbCtD
Pipotiazine—CYP2D6—Niacin—atherosclerosis	0.0513	0.0925	CbGbCtD
Pipotiazine—CYP2D6—Simvastatin—atherosclerosis	0.0406	0.0731	CbGbCtD
Pipotiazine—CYP2D6—Lovastatin—atherosclerosis	0.0397	0.0716	CbGbCtD
Pipotiazine—CYP2D6—Pravastatin—atherosclerosis	0.0397	0.0716	CbGbCtD
Pipotiazine—CYP3A4—Ezetimibe—atherosclerosis	0.0277	0.05	CbGbCtD
Pipotiazine—CYP3A4—Rosuvastatin—atherosclerosis	0.0277	0.05	CbGbCtD
Pipotiazine—CYP3A4—Simvastatin—atherosclerosis	0.0258	0.0465	CbGbCtD
Pipotiazine—CYP3A4—Pravastatin—atherosclerosis	0.0252	0.0455	CbGbCtD
Pipotiazine—CYP3A4—Lovastatin—atherosclerosis	0.0252	0.0455	CbGbCtD
Pipotiazine—HTR2A—arteriole—atherosclerosis	0.00161	0.253	CbGeAlD
Pipotiazine—Aceprometazine—HRH1—atherosclerosis	0.001	0.118	CrCbGaD
Pipotiazine—HTR2A—vein—atherosclerosis	0.000959	0.151	CbGeAlD
Pipotiazine—Methdilazine—HRH1—atherosclerosis	0.00093	0.11	CrCbGaD
Pipotiazine—Alimemazine—HRH1—atherosclerosis	0.000678	0.08	CrCbGaD
Pipotiazine—HTR2A—hindlimb—atherosclerosis	0.000637	0.1	CbGeAlD
Pipotiazine—Mequitazine—HRH1—atherosclerosis	0.000584	0.0689	CrCbGaD
Pipotiazine—HTR2A—appendage—atherosclerosis	0.000547	0.0861	CbGeAlD
Pipotiazine—Zuclopenthixol—HRH1—atherosclerosis	0.000482	0.0568	CrCbGaD
Pipotiazine—Thiothixene—HRH1—atherosclerosis	0.000415	0.049	CrCbGaD
Pipotiazine—Mesoridazine—HRH1—atherosclerosis	0.00041	0.0483	CrCbGaD
Pipotiazine—Prochlorperazine—HRH1—atherosclerosis	0.000397	0.0468	CrCbGaD
Pipotiazine—HTR2A—artery—atherosclerosis	0.000391	0.0615	CbGeAlD
Pipotiazine—Fluphenazine—HRH1—atherosclerosis	0.000359	0.0423	CrCbGaD
Pipotiazine—Propiomazine—HRH1—atherosclerosis	0.000345	0.0407	CrCbGaD
Pipotiazine—HTR2A—endothelium—atherosclerosis	0.00033	0.052	CbGeAlD
Pipotiazine—Thioridazine—HRH1—atherosclerosis	0.000309	0.0365	CrCbGaD
Pipotiazine—HTR2A—blood vessel—atherosclerosis	0.000304	0.0479	CbGeAlD
Pipotiazine—Methotrimeprazine—HRH1—atherosclerosis	0.000295	0.0348	CrCbGaD
Pipotiazine—Promethazine—HRH1—atherosclerosis	0.000291	0.0343	CrCbGaD
Pipotiazine—Trifluoperazine—HRH1—atherosclerosis	0.000287	0.0338	CrCbGaD
Pipotiazine—Perphenazine—HRH1—atherosclerosis	0.000284	0.0335	CrCbGaD
Pipotiazine—Quetiapine—HRH1—atherosclerosis	0.000278	0.0328	CrCbGaD
Pipotiazine—Promazine—HRH1—atherosclerosis	0.000256	0.0302	CrCbGaD
Pipotiazine—SLC22A1—adipose tissue—atherosclerosis	0.000243	0.0383	CbGeAlD
Pipotiazine—HTR1A—cardiovascular system—atherosclerosis	0.000228	0.0359	CbGeAlD
Pipotiazine—Chlorpromazine—HRH1—atherosclerosis	0.000225	0.0266	CrCbGaD
Pipotiazine—Imipramine—HRH1—atherosclerosis	0.000224	0.0264	CrCbGaD
Pipotiazine—SLC22A1—liver—atherosclerosis	0.000171	0.0269	CbGeAlD
Pipotiazine—ALB—liver—atherosclerosis	0.000163	0.0257	CbGeAlD
Pipotiazine—HTR2A—connective tissue—atherosclerosis	0.000156	0.0246	CbGeAlD
Pipotiazine—HTR2A—cardiovascular system—atherosclerosis	0.000136	0.0214	CbGeAlD
Pipotiazine—CYP2C19—liver—atherosclerosis	0.000131	0.0207	CbGeAlD
Pipotiazine—CYP1A2—liver—atherosclerosis	0.000107	0.0169	CbGeAlD
Pipotiazine—Acepromazine—ALB—atherosclerosis	9.97e-05	0.0118	CrCbGaD
Pipotiazine—Thioproperazine—ALB—atherosclerosis	9.75e-05	0.0115	CrCbGaD
Pipotiazine—Thiothixene—ALB—atherosclerosis	9.59e-05	0.0113	CrCbGaD
Pipotiazine—HTR2A—liver—atherosclerosis	8.4e-05	0.0132	CbGeAlD
Pipotiazine—CYP3A4—liver—atherosclerosis	7.77e-05	0.0122	CbGeAlD
Pipotiazine—CYP2D6—liver—atherosclerosis	7.65e-05	0.012	CbGeAlD
Pipotiazine—Clomipramine—ALB—atherosclerosis	7.58e-05	0.00894	CrCbGaD
Pipotiazine—Chlorpromazine—ALB—atherosclerosis	5.2e-05	0.00613	CrCbGaD
Pipotiazine—DRD1—Signaling Pathways—PIK3CG—atherosclerosis	1.26e-05	9.82e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—LPL—atherosclerosis	1.26e-05	9.81e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	1.26e-05	9.79e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.26e-05	9.78e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.24e-05	9.67e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.24e-05	9.67e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.24e-05	9.67e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—APOA2—atherosclerosis	1.24e-05	9.67e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—LPL—atherosclerosis	1.24e-05	9.65e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.23e-05	9.59e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.23e-05	9.56e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—AGT—atherosclerosis	1.23e-05	9.55e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.23e-05	9.55e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PRKCG—atherosclerosis	1.23e-05	9.53e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.22e-05	9.5e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—LIPC—atherosclerosis	1.22e-05	9.5e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.22e-05	9.48e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—APOC3—atherosclerosis	1.21e-05	9.44e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—MAPK3—atherosclerosis	1.21e-05	9.41e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	1.21e-05	9.38e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—LDLR—atherosclerosis	1.21e-05	9.38e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PIK3CG—atherosclerosis	1.2e-05	9.37e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—LEP—atherosclerosis	1.2e-05	9.36e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—APOE—atherosclerosis	1.2e-05	9.36e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—INS—atherosclerosis	1.2e-05	9.3e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SPP1—atherosclerosis	1.19e-05	9.29e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CAV1—atherosclerosis	1.19e-05	9.28e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—APOA1—atherosclerosis	1.19e-05	9.25e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	1.19e-05	9.25e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—VEGFA—atherosclerosis	1.19e-05	9.24e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—LPA—atherosclerosis	1.19e-05	9.23e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CETP—atherosclerosis	1.18e-05	9.16e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CCL2—atherosclerosis	1.18e-05	9.15e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SPP1—atherosclerosis	1.17e-05	9.14e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	1.17e-05	9.1e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—HMOX1—atherosclerosis	1.16e-05	9.06e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PPARG—atherosclerosis	1.16e-05	9.04e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IGF1—atherosclerosis	1.16e-05	9e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—ESR1—atherosclerosis	1.15e-05	8.94e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—BGN—atherosclerosis	1.15e-05	8.93e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—INS—atherosclerosis	1.14e-05	8.87e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—APOA5—atherosclerosis	1.14e-05	8.84e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—F2—atherosclerosis	1.13e-05	8.83e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.13e-05	8.77e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—MAPK3—atherosclerosis	1.12e-05	8.75e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.12e-05	8.72e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—APOB—atherosclerosis	1.12e-05	8.68e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PDGFB—atherosclerosis	1.1e-05	8.59e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—SERPINE1—atherosclerosis	1.1e-05	8.54e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.1e-05	8.54e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.09e-05	8.51e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—TGFB1—atherosclerosis	1.09e-05	8.48e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	1.09e-05	8.46e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	1.09e-05	8.45e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GSTM1—atherosclerosis	1.08e-05	8.44e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—AGT—atherosclerosis	1.08e-05	8.39e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.06e-05	8.29e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—LPL—atherosclerosis	1.06e-05	8.28e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—AGT—atherosclerosis	1.06e-05	8.25e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.06e-05	8.22e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—LEP—atherosclerosis	1.06e-05	8.22e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—APOE—atherosclerosis	1.06e-05	8.22e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—NOS3—atherosclerosis	1.05e-05	8.16e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CAV1—atherosclerosis	1.05e-05	8.14e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.05e-05	8.13e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—ALB—atherosclerosis	1.04e-05	8.13e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—APOA1—atherosclerosis	1.04e-05	8.13e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	1.04e-05	8.09e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—LEP—atherosclerosis	1.04e-05	8.09e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—APOE—atherosclerosis	1.04e-05	8.09e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GPX1—atherosclerosis	1.04e-05	8.08e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CAV1—atherosclerosis	1.03e-05	8.01e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—INS—atherosclerosis	1.03e-05	8e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—APOA1—atherosclerosis	1.03e-05	7.99e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CD36—atherosclerosis	1.01e-05	7.87e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CCL2—atherosclerosis	1.01e-05	7.87e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—ESR1—atherosclerosis	1.01e-05	7.85e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—APOB—atherosclerosis	1e-05	7.79e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—NOS3—atherosclerosis	1e-05	7.78e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—F2—atherosclerosis	9.96e-06	7.75e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IGF1—atherosclerosis	9.94e-06	7.74e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—ESR1—atherosclerosis	9.92e-06	7.72e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—F2—atherosclerosis	9.8e-06	7.63e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GSTM1—atherosclerosis	9.74e-06	7.58e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—HMOX1—atherosclerosis	9.61e-06	7.48e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.6e-06	7.47e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—MTHFR—atherosclerosis	9.59e-06	7.46e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—LPL—atherosclerosis	9.56e-06	7.44e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	9.53e-06	7.42e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ABCA1—atherosclerosis	9.49e-06	7.38e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.48e-06	7.38e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	9.44e-06	7.35e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—LIPC—atherosclerosis	9.42e-06	7.33e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PPARA—atherosclerosis	9.41e-06	7.32e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	9.38e-06	7.3e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—APOC3—atherosclerosis	9.36e-06	7.28e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GPX1—atherosclerosis	9.33e-06	7.26e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—LDLR—atherosclerosis	9.3e-06	7.24e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CXCL8—atherosclerosis	9.3e-06	7.23e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—APOB—atherosclerosis	9.21e-06	7.16e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PTGS2—atherosclerosis	9.14e-06	7.11e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	9.13e-06	7.1e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—AGT—atherosclerosis	9.11e-06	7.09e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CETP—atherosclerosis	9.09e-06	7.07e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CD36—atherosclerosis	9.08e-06	7.07e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—INS—atherosclerosis	9.02e-06	7.02e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NOS3—atherosclerosis	9.01e-06	7.01e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	8.98e-06	6.99e-05	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	8.98e-06	6.99e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GSTM1—atherosclerosis	8.96e-06	6.97e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—APOE—atherosclerosis	8.92e-06	6.94e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—INS—atherosclerosis	8.88e-06	6.91e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CCL2—atherosclerosis	8.88e-06	6.91e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CAV1—atherosclerosis	8.84e-06	6.88e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—IL6—atherosclerosis	8.84e-06	6.88e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—APOA1—atherosclerosis	8.82e-06	6.86e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—LPL—atherosclerosis	8.79e-06	6.84e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CCL2—atherosclerosis	8.74e-06	6.8e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IGF1—atherosclerosis	8.73e-06	6.79e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.7e-06	6.77e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—MTHFR—atherosclerosis	8.61e-06	6.7e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IGF1—atherosclerosis	8.59e-06	6.68e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GPX1—atherosclerosis	8.58e-06	6.67e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PPARA—atherosclerosis	8.44e-06	6.57e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MMP9—atherosclerosis	8.41e-06	6.54e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CD36—atherosclerosis	8.35e-06	6.5e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—NFKB1—atherosclerosis	8.32e-06	6.47e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	8.29e-06	6.45e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.22e-06	6.39e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MAPK8—atherosclerosis	8.18e-06	6.36e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—AGT—atherosclerosis	8.18e-06	6.36e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—AKT1—atherosclerosis	8.16e-06	6.35e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	8.16e-06	6.35e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—HMOX1—atherosclerosis	8.14e-06	6.34e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PIK3CG—atherosclerosis	8.05e-06	6.27e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—APOE—atherosclerosis	8.01e-06	6.23e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	8e-06	6.22e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CAV1—atherosclerosis	7.94e-06	6.18e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—APOA1—atherosclerosis	7.92e-06	6.16e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—MTHFR—atherosclerosis	7.92e-06	6.16e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NOS3—atherosclerosis	7.91e-06	6.16e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—APOB—atherosclerosis	7.8e-06	6.07e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	7.79e-06	6.06e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PPARG—atherosclerosis	7.77e-06	6.05e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PPARA—atherosclerosis	7.77e-06	6.04e-05	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	7.72e-06	6.01e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—INS—atherosclerosis	7.62e-06	5.93e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	7.6e-06	5.92e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GSTM1—atherosclerosis	7.59e-06	5.9e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—AKT1—atherosclerosis	7.58e-06	5.9e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	7.55e-06	5.88e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—AGT—atherosclerosis	7.52e-06	5.85e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—STAT3—atherosclerosis	7.48e-06	5.82e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—LPL—atherosclerosis	7.45e-06	5.79e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—APOE—atherosclerosis	7.37e-06	5.73e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.32e-06	5.7e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CAV1—atherosclerosis	7.3e-06	5.68e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—APOA1—atherosclerosis	7.28e-06	5.67e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GPX1—atherosclerosis	7.27e-06	5.65e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	7.23e-06	5.63e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.23e-06	5.63e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	7.15e-06	5.57e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	7.14e-06	5.56e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CD36—atherosclerosis	7.08e-06	5.51e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	7.03e-06	5.47e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	7.02e-06	5.46e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	7.01e-06	5.46e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PPARG—atherosclerosis	6.98e-06	5.43e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	6.93e-06	5.39e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	6.91e-06	5.37e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—INS—atherosclerosis	6.84e-06	5.33e-05	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	6.78e-06	5.28e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.71e-06	5.22e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—NOS3—atherosclerosis	6.69e-06	5.2e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—IL6—atherosclerosis	6.67e-06	5.19e-05	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	6.67e-06	5.19e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	6.65e-06	5.17e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PPARA—atherosclerosis	6.58e-06	5.12e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	6.57e-06	5.11e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	6.49e-06	5.05e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	6.43e-06	5e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PPARG—atherosclerosis	6.42e-06	4.99e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—AGT—atherosclerosis	6.37e-06	4.96e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MMP9—atherosclerosis	6.35e-06	4.94e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—INS—atherosclerosis	6.3e-06	4.9e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.28e-06	4.89e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	6.28e-06	4.89e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ALB—atherosclerosis	6.27e-06	4.88e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	6.25e-06	4.86e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—APOE—atherosclerosis	6.24e-06	4.86e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CAV1—atherosclerosis	6.19e-06	4.81e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	6.18e-06	4.81e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	6.17e-06	4.8e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—APOA1—atherosclerosis	6.17e-06	4.8e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	6.16e-06	4.79e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	6.14e-06	4.78e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PTGS2—atherosclerosis	6.12e-06	4.76e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	6.08e-06	4.73e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	6.06e-06	4.71e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—APOB—atherosclerosis	6.02e-06	4.68e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—NOS3—atherosclerosis	6e-06	4.67e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	5.96e-06	4.64e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.86e-06	4.56e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ALB—atherosclerosis	5.77e-06	4.49e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—LPL—atherosclerosis	5.75e-06	4.47e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	5.7e-06	4.44e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—STAT3—atherosclerosis	5.65e-06	4.39e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.63e-06	4.38e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	5.61e-06	4.37e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GPX1—atherosclerosis	5.61e-06	4.36e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	5.55e-06	4.32e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—NOS3—atherosclerosis	5.52e-06	4.3e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.49e-06	4.27e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CD36—atherosclerosis	5.46e-06	4.25e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PPARG—atherosclerosis	5.44e-06	4.23e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	5.39e-06	4.2e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—INS—atherosclerosis	5.33e-06	4.15e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	5.31e-06	4.13e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	5.23e-06	4.07e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL6—atherosclerosis	5.22e-06	4.06e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.18e-06	4.03e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	5.15e-06	4.01e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PPARA—atherosclerosis	5.08e-06	3.95e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.05e-06	3.93e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—AGT—atherosclerosis	4.92e-06	3.83e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ALB—atherosclerosis	4.89e-06	3.8e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—AKT1—atherosclerosis	4.82e-06	3.75e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—APOE—atherosclerosis	4.82e-06	3.75e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CAV1—atherosclerosis	4.77e-06	3.71e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—APOA1—atherosclerosis	4.76e-06	3.71e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—NOS3—atherosclerosis	4.68e-06	3.64e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—AKT1—atherosclerosis	4.59e-06	3.58e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL6—atherosclerosis	4.49e-06	3.49e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.35e-06	3.38e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.28e-06	3.33e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PPARG—atherosclerosis	4.2e-06	3.27e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	4.14e-06	3.22e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—INS—atherosclerosis	4.12e-06	3.2e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL6—atherosclerosis	3.94e-06	3.07e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL6—atherosclerosis	3.88e-06	3.02e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ALB—atherosclerosis	3.77e-06	2.94e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—AKT1—atherosclerosis	3.64e-06	2.83e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—NOS3—atherosclerosis	3.61e-06	2.81e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	3.58e-06	2.79e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.3e-06	2.57e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—AKT1—atherosclerosis	3.07e-06	2.39e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—AKT1—atherosclerosis	2.76e-06	2.15e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—AKT1—atherosclerosis	2.54e-06	1.97e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—AKT1—atherosclerosis	2.15e-06	1.67e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.66e-06	1.29e-05	CbGpPWpGaD
